Overview Fundamentals API Earnings EOD API Sample Code Pricing

VAXCYTE INC. DL -001 (5VA F) stock market data APIs

€96.5 0(0%) as of October 30, 2024
Price chart is built with Anychart

Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine for the prevention of invasive pneumococcal disease. The company also develops VAX-31 to protect against emerging strains and to help address antibiotic resistance; VAX-A1, a novel conjugate vaccine candidate to prevent disease caused by Group A Streptococcus; VAX-PG, a novel protein vaccine candidate targeting keystone pathogen responsible for periodontitis; and VAX-GI to prevent Shigella, a bacterial illness. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.

VAXCYTE INC. DL -001 Financial Data Overview

96.5
96.5
-
96.5
96.5
43.4-108
11 945 M
124 M
0
0.993
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: '5VA',
Type: 'Common Stock',
Name: 'VAXCYTE INC. DL -001',
Exchange: 'F',
CurrencyCode: 'EUR',
CurrencyName: 'Euro',
CurrencySymbol: '€',
CountryName: 'Germany',
CountryISO: 'DE',
OpenFigi: NULL,
ISIN: NULL,
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
CUSIP: NULL,
}

VAXCYTE INC. DL -001 Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -573 110 976
  • Earnings Per Share -4.34
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get VAXCYTE INC. DL -001 Earnings via APIs

  • Latest Release 2024-11-04
  • EPS/Forecast NaN

Get VAXCYTE INC. DL -001 End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com